Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1826-18-2

Post Buying Request

1826-18-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1826-18-2 Usage

Description

Thiazole, 5-methyl-4-phenylis a heterocyclic aromatic compound that features a thiazole ring with a methyl group and a phenyl group substituent. It is widely recognized for its diverse range of biological activities, such as antimicrobial, antiviral, and anticancer properties, and is a key component in the synthesis of drugs, dyes, pigments, and other organic compounds within the pharmaceutical industry.

Uses

Used in Pharmaceutical Industry:
Thiazole, 5-methyl-4-phenylis utilized as a key intermediate in the synthesis of various drugs, leveraging its unique structure and biological activities to contribute to the development of new therapeutic agents.
Used in Antimicrobial Applications:
This chemical compound serves as an antimicrobial agent, effectively combating a range of microbial infections due to its inherent properties.
Used in Antiviral Applications:
Thiazole, 5-methyl-4-phenylis employed as an antiviral agent, helping to inhibit the replication and spread of viruses, thereby providing a potential treatment option for viral infections.
Used in Anticancer Applications:
It is used as an anticancer agent, where its biological activities contribute to the inhibition of tumor growth and the progression of cancer, offering a potential therapeutic approach for cancer treatment.
Used in Dye and Pigment Production:
Thiazole, 5-methyl-4-phenylis used as an intermediate in the production of dyes and pigments, capitalizing on its chemical structure to create a variety of colorants for different industries.
Used in Neurological Disorder Treatment:
Thiazole, 5-methyl-4-phenylhas been studied for its potential role in the treatment of neurological disorders, suggesting that it may have therapeutic benefits in managing such conditions.
Used in Drug Development:
As a building block for the development of new drugs, Thiazole, 5-methyl-4-phenylplays a crucial role in the creation of pharmaceuticals with specific therapeutic benefits, contributing to advancements in medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 1826-18-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,2 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1826-18:
(6*1)+(5*8)+(4*2)+(3*6)+(2*1)+(1*8)=82
82 % 10 = 2
So 1826-18-2 is a valid CAS Registry Number.

1826-18-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-methyl-4-phenyl-1,3-thiazole

1.2 Other means of identification

Product number -
Other names 4-Phenyl-5-methyl-thiazol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1826-18-2 SDS

1826-18-2Relevant articles and documents

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors

Nitta, Aiko,Fujii, Hideaki,Sakami, Satoshi,Satoh, Mikiya,Nakaki, Junko,Satoh, Shiho,Kumagai, Hiroki,Kawai, Hideki

, p. 7036 - 7040 (2013/01/15)

A series of novel 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides were investigated as dipeptidyl peptidase IV (DPP-4) inhibitors. Introduction of a 4-phenylthiazol-2-yl group showed highly potent DPP-4 inhibitory activity. Among various derivatives, (3R)-3-amino-N-(4-(4-phenylthiazol-2-yl)-tetrahydro-2H- thiopyran-4-yl)-4-(2,4,5-trifluorophenyl)butanamide 1,1-dioxide (30) reduced blood glucose excursion in an oral glucose tolerance test by oral administration.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1826-18-2